PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VIVA Biotech Holdings (1873.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

KYG9390W1015

Sector

Healthcare

Highlights

Market Cap

HK$4.29B

Year Range

HK$0.41 - HK$2.05

Target Price

HK$7.76

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
1873.HK vs. AGI 1873.HK vs. KGC
Popular comparisons:
1873.HK vs. AGI 1873.HK vs. KGC

Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in VIVA Biotech Holdings, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%OctoberNovemberDecember2025FebruaryMarch
-55.84%
97.15%
1873.HK (VIVA Biotech Holdings)
Benchmark (^GSPC)

Returns By Period

VIVA Biotech Holdings had a return of 122.99% year-to-date (YTD) and 266.04% in the last 12 months.


1873.HK

YTD

122.99%

1M

34.72%

6M

198.46%

1Y

266.04%

5Y*

-13.93%

10Y*

N/A

^GSPC (Benchmark)

YTD

-2.88%

1M

-4.53%

6M

-0.18%

1Y

9.77%

5Y*

17.66%

10Y*

10.76%

*Annualized

Monthly Returns

The table below presents the monthly returns of 1873.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-8.05%65.00%122.99%
2024-39.05%-7.81%-8.47%-1.85%16.98%-14.52%1.89%9.26%61.02%2.11%-7.22%-3.33%-17.14%
20236.29%-15.05%-5.70%8.05%-4.97%-1.96%14.67%-15.12%-13.70%1.59%-10.94%-7.89%-40.00%
2022-24.20%-15.97%3.33%-19.35%-0.40%9.24%-22.43%-11.85%-28.49%-10.53%40.34%4.79%-62.85%
2021-17.94%-10.53%-0.15%-0.00%62.39%-8.55%-22.74%-11.72%-9.73%-3.76%-20.71%0.86%-48.42%
2020-16.45%11.29%-3.77%14.71%52.35%21.98%4.26%1.44%-3.29%-16.70%-2.44%26.94%101.25%
2019-7.92%-16.71%23.01%-2.16%10.18%3.56%-7.74%6.29%3.29%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 96, 1873.HK is among the top 4% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of 1873.HK is 9696
Overall Rank
The Sharpe Ratio Rank of 1873.HK is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of 1873.HK is 9797
Sortino Ratio Rank
The Omega Ratio Rank of 1873.HK is 9494
Omega Ratio Rank
The Calmar Ratio Rank of 1873.HK is 9595
Calmar Ratio Rank
The Martin Ratio Rank of 1873.HK is 9494
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for VIVA Biotech Holdings (1873.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for 1873.HK, currently valued at 2.89, compared to the broader market-2.00-1.000.001.002.003.002.890.66
The chart of Sortino ratio for 1873.HK, currently valued at 3.91, compared to the broader market-4.00-2.000.002.004.003.910.96
The chart of Omega ratio for 1873.HK, currently valued at 1.43, compared to the broader market0.501.001.502.001.431.13
The chart of Calmar ratio for 1873.HK, currently valued at 2.69, compared to the broader market0.001.002.003.004.005.002.690.90
The chart of Martin ratio for 1873.HK, currently valued at 10.10, compared to the broader market0.005.0010.0015.0020.0010.103.12
1873.HK
^GSPC

The current VIVA Biotech Holdings Sharpe ratio is 2.89. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of VIVA Biotech Holdings with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2025FebruaryMarch
2.89
0.61
1873.HK (VIVA Biotech Holdings)
Benchmark (^GSPC)

Dividends

Dividend History

VIVA Biotech Holdings provided a 0.00% dividend yield over the last twelve months, with an annual payout of HK$0.00 per share.


0.00%0.05%0.10%0.15%0.20%0.25%0.30%0.35%HK$0.00HK$0.01HK$0.01HK$0.02HK$0.02HK$0.03HK$0.03HK$0.04201920202021202220232024
Dividends
Dividend Yield
PeriodTTM202420232022202120202019
DividendHK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.03HK$0.01

Dividend yield

0.00%0.00%0.00%0.00%0.21%0.35%0.11%

Monthly Dividends

The table displays the monthly dividend distributions for VIVA Biotech Holdings. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025HK$0.00HK$0.00HK$0.00HK$0.00
2024HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.02HK$0.00HK$0.00HK$0.02HK$0.00HK$0.00HK$0.00HK$0.03
2019HK$0.01HK$0.00HK$0.00HK$0.00HK$0.01

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2025FebruaryMarch
-82.55%
-7.04%
1873.HK (VIVA Biotech Holdings)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the VIVA Biotech Holdings. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the VIVA Biotech Holdings was 96.27%, occurring on Apr 19, 2024. The portfolio has not yet recovered.

The current VIVA Biotech Holdings drawdown is 82.55%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.27%Jun 24, 2021695Apr 19, 2024
-41.96%Aug 10, 2020173Apr 22, 202124May 27, 2021197
-37.84%May 16, 201928Jun 25, 2019219May 13, 2020247
-24.27%Jul 10, 20205Jul 16, 202014Aug 5, 202019
-13.67%May 22, 20201May 22, 20202May 26, 20203

Volatility

Volatility Chart

The current VIVA Biotech Holdings volatility is 30.06%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%OctoberNovemberDecember2025FebruaryMarch
30.06%
6.11%
1873.HK (VIVA Biotech Holdings)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of VIVA Biotech Holdings over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for VIVA Biotech Holdings.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab